Fake Cancer Drugs Flood Pakistan: Patients at Risk Amid Shortages

Counterfeit Cancer Drugs Threaten Patient Safety in Pakistan

Pakistan is grappling with a dangerous surge of counterfeit cancer drugs as shortages of modern therapies push desperate patients toward the grey market. With life-saving immunotherapies like pembrolizumab and nivolumab largely unavailable through legal channels, families are left with few options—and many are falling victim to fake medicines.

Oncologists across the country are sounding the alarm. They report vials with visible particles, unclear solutions, and incorrect quantities—clear signs of falsified products. Patients relying on these counterfeit drugs often show no clinical improvement, and in some cases, their conditions worsen rapidly. The financial burden is equally devastating, as families spend thousands of rupees on treatments that provide no benefit.

Experts point to systemic failures as the root cause. The Drug Regulatory Authority of Pakistan (DRAP) has approved prices for key cancer drugs, but delays in federal cabinet notifications prevent legal imports. This bureaucratic bottleneck has created a vacuum, allowing smugglers and counterfeiters to exploit vulnerable patients. Pharmacies are frequently approached for unregistered medicines, highlighting the scale of the crisis.

The Pakistan Medical Association has described the situation as a humanitarian emergency. Without immediate government intervention, counterfeit drugs will continue to flood the market, undermining patient safety and trust in the healthcare system. Strict enforcement against illegal networks and expedited regulatory approvals are urgently needed to restore access to genuine therapies.

For cancer patients in Pakistan, the stakes could not be higher. Until modern treatments are made legally available, thousands remain exposed to ineffective and harmful counterfeit drugs. Addressing this crisis is not just about regulation—it’s about protecting lives and ensuring that every patient has the chance to fight their disease with real medicine.